|
A-to-I |
Downstream |
87 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
103 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
111 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
112 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
115 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
127 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
136 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
175 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
177 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
206 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
228 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
228 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.
|
A-to-I |
Downstream |
228 |
Decreased |
Brain |
Reduce the quantity of Skp2 target protein |
NA |
Reduce RNA editing in disease |
|
|
CDC14B editing and expression are progressively impaired in astrocytomas from grade I to IV, being very low in GBMs.